These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15471508)

  • 41. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options.
    Naesdal J; Brown K
    Drug Saf; 2006; 29(2):119-32. PubMed ID: 16454539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The iatrogenic costs of NSAID therapy: a population study.
    Sturkenboom MC; Romano F; Simon G; Correa-Leite ML; Villa M; Nicolosi A; Borgnolo G; Bianchi-Porro G; Mannino S
    Arthritis Rheum; 2002 Apr; 47(2):132-40. PubMed ID: 11954006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rate of prescribing gastrointestinal prophylaxis with either a proton pump inhibitor or an H2-receptor antagonist in Nova Scotia seniors starting nonsteroidal anti-inflammatory drug therapy.
    Superceanu B; Veldhuyzen van Zanten S; Skedgel C; Shepherd M; Sketris I
    Can J Gastroenterol; 2010 Aug; 24(8):481-8. PubMed ID: 20711527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin.
    Cheetham TC; Levy G; Niu F; Bixler F
    Ann Pharmacother; 2009 Nov; 43(11):1765-73. PubMed ID: 19809010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adverse Drug Events Involving COX-2 Inhibitors.
    Verrico MM; Weber RJ; McKaveney TP; Ansani NT; Towers AL
    Ann Pharmacother; 2003 Sep; 37(9):1203-13. PubMed ID: 12921500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond.
    Becker JC; Domschke W; Pohle T
    Br J Clin Pharmacol; 2004 Dec; 58(6):587-600. PubMed ID: 15563357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis.
    Burke TA; Zabinski RA; Pettitt D; Maniadakis N; Maurath CJ; Goldstein JL
    Pharmacoeconomics; 2001; 19 Suppl 1():33-47. PubMed ID: 11280104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What is the most effective therapy for preventing NSAID-induced gastropathy?
    Chandramouli J
    J Pain Palliat Care Pharmacother; 2002; 16(2):23-36. PubMed ID: 14650458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NSAID-related psychiatric adverse events: who is at risk?
    Onder G; Pellicciotti F; Gambassi G; Bernabei R
    Drugs; 2004; 64(23):2619-27. PubMed ID: 15537366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.
    Watson DJ; Harper SE; Zhao PL; Quan H; Bolognese JA; Simon TJ
    Arch Intern Med; 2000 Oct; 160(19):2998-3003. PubMed ID: 11041909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The risks and costs of upper gastrointestinal disease attributable to NSAIDs.
    Smalley WE; Griffin MR
    Gastroenterol Clin North Am; 1996 Jun; 25(2):373-96. PubMed ID: 9229579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.
    Arellano FM; Yood MU; Wentworth CE; Oliveria SA; Rivero E; Verma A; Rothman KJ
    Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):861-72. PubMed ID: 17086563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastrointestinal risk of non-steroidal anti-inflammatory drugs and gastroprotective agents used in the treatment of osteoarthritis in elderly patients: A nationwide retrospective cohort study
.
    Han MH; Nam JH; Noh E; Lee EK
    Int J Clin Pharmacol Ther; 2019 Nov; 57(11):531-541. PubMed ID: 31397273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies.
    Pilotto A; Franceschi M; Leandro G; Di Mario F;
    Drugs Aging; 2003; 20(9):701-10. PubMed ID: 12831293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Selective" switching from non-selective to selective non-steroidal anti-inflammatory drugs.
    Bennett K; Teeling M; Feely J
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):645-9. PubMed ID: 12942226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The double-edged sword of COX-2 selective NSAIDs.
    Wright JM
    CMAJ; 2002 Nov; 167(10):1131-7. PubMed ID: 12427705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.